Trials / Completed
CompletedNCT06327048
Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment
Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive Impairment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- YuanYuan Ma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to form an interdisciplinary team to dynamically evaluate patient cognitive outcomes and develop an individualized cognitive training program for Chinese brain tumor patients
Detailed description
Adult patients diagnosed with glioma who meet the inclusion criteria will be enrolled in this study. Patients admitted to Neurosurgery Ward 1 will be assigned to the intervention group, while those admitted to Neurosurgery Ward 2，ward 3 and Ward 4 will serve as the control group. The intervention group will receive cognitive rehabilitation training based on the Remind strategy in addition to standard rehabilitation care, whereas the control group will receive only standard rehabilitation care. Assessment of patients' cognitive function, quality of life, psychological status, and the effectiveness of cognitive training intervention will be conducted on the first day of admission, before intervention, at the end of the 4-week and 12-week intervention .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Individual cognitive rehabilitation training based on Remind strategy was given | This training educates and learns patients from the aspects of assessment of cognitive function and strategic compensation for the impact of cognitive impairment on patients, and then conducts attention, memory and executive function training and attention retraining based on patients' cognitive function to improve patients' cognitive function |
Timeline
- Start date
- 2024-01-21
- Primary completion
- 2025-01-12
- Completion
- 2025-01-12
- First posted
- 2024-03-25
- Last updated
- 2025-08-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06327048. Inclusion in this directory is not an endorsement.